R-LAB CHEMICAL ANALYSIS ACCORDING TO YOUR WISHES

Importance of the topic

Advanced, validated analytical services are essential for regulatory compliance, product quality and safety in pharmaceutical development, environmental monitoring and advanced materials research. Precise elemental and molecular analyses at trace and ultratrace levels enable risk assessment of elemental impurities (ICH-Q3D), identification and structural elucidation of organic impurities, and spatial mapping of analytes in complex matrices. Centralized facilities that combine regulatory know‑how, high‑end instrumentation and method validation expertise accelerate development timelines and reduce analytical uncertainty for industry and academia.

Objectives and overview of the service

This document describes R‑LAB, an analytical service group embedded in the Regional Centre of Advanced Technologies and Materials (RCPTM) and the Department of Analytical Chemistry at Palacký University Olomouc. The lab provides tailored analytical method development, validation and contract testing, with a primary focus on pharmaceutical analysis under Good Manufacturing Practice (GMP). Key service areas include quantification of elemental impurities according to ICH‑Q3D and USP guidelines, trace elemental and molecular analysis, mass spectrometry imaging, speciation studies and standard HPLC/LC‑MS workflows for trace organic impurities and degradation studies.

Methodology and analytical approach

R‑LAB applies a multi‑technique analytical strategy matched to client needs. Core methodologies include:

• Inductively coupled plasma mass spectrometry (ICP‑MS) for quantification of elemental impurities down to ng/L levels and compliance testing against ICH‑Q3D requirements.
• Laser ablation ICP‑MS (LA‑ICP‑MS) and matrix‑assisted laser desorption/ionization mass spectrometry (MALDI‑MS) for spatially resolved mass spectrometry imaging of elements and small molecules in heterogeneous samples.
• HPLC coupled to ICP‑MS (HPLC‑ICP‑MS) for element speciation analyses, enabling differentiation of chemical forms with distinct toxicological properties.
• HPLC with UV and/or MS detection and tandem mass spectrometry for impurity profiling, quantitation of trace organic contaminants and structure elucidation of unknowns.
• Standardized stability, solubility and degradation studies combined with analytical method validation under GMP principles.

Instrumentation used

• Quadrupole and sector‑field ICP‑MS platforms for bulk elemental quantification and ultratrace analysis.
• LA‑ICP‑MS systems for element imaging with spatial resolution suitable for materials and biological samples.
• MALDI‑MS instrumentation for molecular imaging of small molecules and biomolecules in tissue and material sections.
• HPLC systems coupled to UV detectors and single‑/tandem MS for organic impurity analysis and structural workups.
• HPLC‑ICP‑MS hyphenations for element‑specific speciation studies.

Main capabilities and discussion of performance

R‑LAB emphasizes validated workflows and regulatory alignment. Typical analytical capabilities include elemental detection limits in the ng/L range for ICP‑MS assays, validated quantitation compliant with GMP and ICH‑Q3D criteria, and combined molecular/elemental imaging that links chemical identity with spatial distribution. Speciation analyses support risk‑based assessment by separating and quantifying toxicologically relevant forms. HPLC‑MS approaches are used for trace organic impurity profiling and for identifying degradation products; the laboratory also offers structural elucidation services using MS fragmentation data and complementary orthogonal techniques. The combination of method validation, experienced interpretation and trace‑level sensitivity makes the facility suited for pharmaceutical QA/QC, research, and material characterization.

Practical benefits and applications

• Pharmaceutical industry: ICH‑Q3D elemental impurity testing, stability and degradation studies, impurity identification and GMP‑compliant testing.
• Materials science: elemental mapping and compositional analysis of advanced materials, coatings and device components.
• Biomedical research: mass spectrometry imaging to localize metals and small molecules in tissues and biomaterials.
• Environmental and food analysis: ultratrace elemental determinations and speciation to assess exposure and compliance.
• Regulatory support: validated methods, documentation and workflows aligned with GMP to support submissions and quality systems.

Future trends and potential applications

The analytical landscape will continue to evolve toward greater sensitivity, spatial resolution and data integration. Relevant trends include:

• Deeper hyphenation of separation and detection techniques (e.g., LC‑ICP‑MS, LC‑MS/MS) for robust speciation and impurity characterization.
• Improved imaging resolution and multimodal imaging workflows combining elemental and molecular maps to better understand structure–function relationships in materials and tissues.
• Enhanced sensitivity via novel ionization strategies and high‑resolution mass analyzers to push limits of detection below current ng/L thresholds for challenging matrices.
• Automation, advanced data processing and machine learning for pattern recognition, peak deconvolution and accelerated structure elucidation workflows.
• Growing emphasis on green analytical chemistry and miniaturized sample preparation to reduce solvent and sample consumption while maintaining regulatory compliance.

Conclusion

R‑LAB provides a comprehensive, regulatory‑aware analytical service platform combining high‑end ICP‑MS, mass spectrometry imaging and LC‑MS capabilities with GMP‑compliant method development and validation. Its strengths lie in ultratrace elemental analysis, speciation, imaging and trace organic impurity workflows, making it a versatile partner for pharmaceutical, materials and environmental applications. Continuous adoption of advanced instrumentation and data science methods will further expand the lab's ability to address emerging analytical challenges.

References

No formal literature references were provided in the source document. Contact information and institutional affiliation originate from the source brochure material.